Download the Schwab app from iTunes®Get the AppClose

  • Find a branch
To expand the menu panel use the down arrow key. Use Tab to navigate through submenu items.

health-care-stethoscope-scrubs_1187x528

Health Care Sector Rating: Outperform

Health care sector overview

In general, health care companies' balance sheets are solid, their stocks have offered attractive dividend yields and the sector's overall cost structure appears to have improved. Demand appears to be on the rise for health care products and services. On the other hand, political rhetoric around the Affordable Care Act can be expected to fuel continued volatility.

Market outlook for the health care sector

Competition concerns and regulatory worries appear to continue to weigh on the health care sector at times. We don’t discount these issues, but we believe that the concerns are overdone at this point in time. As for the fears of drug price controls, we continue to believe that’s a non-starter as long the Republicans control Congress—so we believe the recent pullback is a potential opportunity to get into the group.

In our view the health care sector has a lot of positives going for it and has had decent performance over the past year—but we think there’s improving performance to come. Valuations appear fair to slightly below average based on historical levels, balance sheets are solid, stocks generally have good dividend yields, and the overall cost structure appears to be much improved. Also, demand appears to be on the rise for health care products and services, partly as a result of an aging population.

The Affordable Care Act continues to be a potential source of volatility for the sector, but we believe this creates potential opportunities for investors and are currently rating the group at outperform. While a broad-based repeal seems highly unlikely in the near-term, there are smaller changes being made administratively and proposed legislatively that will likely continue to result in ebbs and flows in the sector as investors tried to gauge the impact on various areas of the sector. This is a story that will continue to develop over the next several months, at least. This will likely keep the health care sector a bit more volatile than usual, but also create some opportunities for investors willing to ride the potential roller coaster. Another factor potentially helping the group, the Federal Reserve continues to raise rates and—according to BCA Research—the sector has outperformed during Fed hiking cycles on average since 1970. Since past performance does not guarantee future results, we acknowledge that there are risks and it could be a bit of a bumpy ride, but we believe that brighter prospects are ahead and remain comfortable with our outperform rating on the group.

We believe an outperform rating for the entire sector is appropriate, although at times it will feel disappointing as the sector experiences both short-term dips on speculation as to what changes may or may not occur, but we urge investors to remain patient and ride out these short-term potential storms.

Factors that may affect the health care sector

Positive factors for the health care sector include:

  • Increased need for services: An aging population requires more extensive drug treatments and medical care. The health issues associated with obesity also could boost demand for medical services.
  • Strong financials: Balance sheets in the health care sector remain flush with cash, increasing the possibility of higher dividend payments, share-enhancing stock buybacks, and mergers and acquisitions.

Negative factors for the health care sector include:

  • Regulatory uncertainty: Despite the elevated rancor in Washington and Republican to this point unable to agree on a way forward, the ACA and other health care-related policies still seem likely to change at least somewhat, but what those changes may be are virtually unknowable at this point.
  • Fiscal policy concerns: The current fiscal situation in Washington creates uncertainty regarding the health care sector. Certain funding mechanisms could be changed as Congress deals with growing deficits.

Clients can see our top-rated stocks in the health care sector.

Want to learn more about a specific sector?  Click on a link below for more information or visit Schwab Sector Views to see how they compare.

Consumer discretionary Consumer staples Energy
Financials Health care Industrials
Information technology Materials Real estate
Telecom Utilities

What You Can Do Next

 

Consumer Discretionary Sector Rating: Marketperform
Energy Sector Rating: Marketperform
Energy Sector

Important Disclosures

Schwab Sector Views do not represent a personalized recommendation of a particular investment strategy to you. You should not buy or sell an investment without first considering whether it is appropriate for you and your portfolio. Additionally, you should review and consider any recent market news.

All expressions of opinion are subject to change without notice in reaction to shifting market conditions. Data contained herein from third-party providers is obtained from what are considered reliable sources. However, its accuracy, completeness or reliability cannot be guaranteed.

Diversification strategies do not ensure a profit and do not protect against losses in declining markets.

Indexes are unmanaged, do not incur management fees, costs and expenses, and cannot be invested in directly. Past performance is no guarantee of future results.

The S&P 500 Index is a market-capitalization-weighted index comprising 500 widely traded stocks chosen for market size, liquidity and industry group representation.

The Global Industry Classification Standard (GICS) was developed by and is the exclusive property of Morgan Stanley Capital International Inc. (MSCI) and Standard & Poor's. GICS is a service mark of MSCI and S&P and has been licensed for use by Charles Schwab & Co., Inc.

The Schwab Center for Financial Research is a division of Charles Schwab & Co., Inc.

(0518-83GB)

Thumbs up / down votes are submitted voluntarily by readers and are not meant to suggest the future performance or suitability of any account type, product or service for any particular reader and may not be representative of the experience of other readers. When displayed, thumbs up / down vote counts represent whether people found the content helpful or not helpful and are not intended as a testimonial. Any written feedback or comments collected on this page will not be published. Charles Schwab & Co., Inc. may in its sole discretion re-set the vote count to zero, remove votes appearing to be generated by robots or scripts, or remove the modules used to collect feedback and votes.